FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
Drugs.com
JULY 21, 2025
Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). MONDAY, July 21, 2025 -- The U.S. The existing vaccine consists of two.
Let's personalize your content